Recombinant Francisella tularensis subsp. tularensis Glucose-6-phosphate isomerase (pgi), partial

What is the role of Glucose-6-phosphate isomerase in F. tularensis metabolism?

Glucose-6-phosphate isomerase (pgi) catalyzes the reversible isomerization of glucose-6-phosphate to fructose-6-phosphate, serving as a critical junction between glycolysis and gluconeogenesis in F. tularensis. This enzyme is particularly important for F. tularensis as the pathogen undergoes significant metabolic adaptation during different stages of infection.

During early stages of infection, F. tularensis primarily utilizes oxidative metabolism through the TCA cycle, whereas later stages show a metabolic shift to fatty acid oxidation and gluconeogenesis . This metabolic flexibility allows F. tularensis to adapt to changing nutrient availability within host macrophages. The pgi enzyme facilitates this metabolic plasticity by enabling the interconversion between glucose-6-phosphate and fructose-6-phosphate, supporting both energy production and biosynthetic processes.

How is pgi expression regulated during F. tularensis infection cycles?

The expression of pgi in F. tularensis is tightly regulated during infection, reflecting its important role in metabolic adaptation. Transcriptomic analyses have revealed that F. tularensis modulates sugar catabolism by switching from oxidative metabolism (TCA cycle) in the initial stages of infection to fatty acid oxidation and gluconeogenesis later on .

The regulation of pgi likely involves multiple transcription factors, including GreA, which has been identified as a key virulence factor in F. tularensis. GreA influences the expression of numerous virulence-associated genes , potentially including those involved in central metabolism like pgi. Research indicates that only a limited set of metabolic genes are operational during infection, suggesting that pgi expression may be precisely controlled to optimize bacterial survival in the intracellular environment.

What are the structural characteristics of F. tularensis pgi compared to other bacterial homologs?

F. tularensis pgi maintains the conserved catalytic domains found in other bacterial glucose-6-phosphate isomerases but exhibits distinct structural features that may influence its activity and regulation. The enzyme typically exists as a dimer with each monomer containing a catalytic domain and a sugar isomerase domain.

These structural differences may contribute to the unique kinetic properties of F. tularensis pgi and could potentially be exploited for the development of selective inhibitors as therapeutic agents.

What are the optimal expression systems for producing recombinant F. tularensis pgi?

The expression of recombinant F. tularensis pgi presents several challenges due to protein solubility issues and the need to maintain enzymatic activity. Based on current research methodologies, the following expression systems have proven effective:

E. coli-based expression systems:

• BL21(DE3) strain with pET vector systems containing the pgi gene under the control of a T7 promoter

• Temperature optimization: expression at lower temperatures (16-20°C) following IPTG induction to enhance protein solubility

• Codon optimization: adapting the F. tularensis pgi gene sequence to E. coli codon usage

• Fusion tags: incorporating solubility enhancing tags such as MBP (maltose-binding protein) or SUMO

Protocol recommendations:

• Transform expression vector into E. coli BL21(DE3)

• Grow cultures at 37°C to OD600 of 0.6-0.8

• Induce with 0.1-0.5 mM IPTG

• Shift temperature to 18°C and continue expression for 16-18 hours

• Harvest cells and lyse using sonication or French press

• Purify using affinity chromatography followed by size exclusion chromatography

This approach typically yields 3-5 mg of purified recombinant pgi per liter of bacterial culture with >90% purity and preserved enzymatic activity.

What are the standard assays to measure F. tularensis pgi activity and inhibition?

Several robust assays have been developed to measure the enzymatic activity of F. tularensis pgi and to evaluate potential inhibitors:

Spectrophotometric coupled assay:
This is the most commonly used method for measuring pgi activity. The assay couples the production of fructose-6-phosphate to subsequent enzymatic reactions that result in the reduction of NAD+ to NADH, which can be monitored at 340 nm.

Reaction components:

• Recombinant F. tularensis pgi (0.1-1 μg)

• Glucose-6-phosphate (1-5 mM)

• Phosphofructokinase (1-2 units)

• Aldolase (1-2 units)

• Triosephosphate isomerase (10 units)

• Glycerol-3-phosphate dehydrogenase (2 units)

• ATP (1 mM)

• NAD+ (0.5 mM)

• MgCl₂ (5 mM)

• Buffer: 50 mM Tris-HCl, pH 7.4

For inhibition studies, potential inhibitors are pre-incubated with the enzyme for 10-15 minutes before initiating the reaction by adding the substrate. IC50 values are determined by testing a range of inhibitor concentrations and analyzing the dose-response curve.

Alternative methods:

• Direct measurement of substrate/product using HPLC

• Isothermal titration calorimetry for enzyme kinetics and inhibitor binding

• Nuclear magnetic resonance (NMR) for real-time monitoring of the enzymatic reaction

These methodologies provide comprehensive tools for characterizing the catalytic properties of F. tularensis pgi and evaluating its interactions with inhibitors.

How can I develop a pgi knockout strain of F. tularensis for functional studies?

Developing a pgi knockout strain of F. tularensis requires careful consideration of biosafety regulations due to the pathogen's high virulence. Most researchers use the attenuated F. tularensis subsp. novicida or the live vaccine strain (LVS) for genetic manipulation studies.

Recommended approaches:

• Homologous recombination method:

  • Design PCR primers to amplify flanking regions (500-1000 bp) of the pgi gene

  • Clone these regions into a suicide vector with an antibiotic resistance marker

  • Transform the construct into F. tularensis using electroporation

  • Select for recombinants on antibiotic-containing media

  • Confirm deletion by PCR and functional assays

• Group II intron retargeting system (TargeTron):

  • Design intron retargeting sequences specific to the pgi gene

  • Clone the modified intron into the appropriate vector

  • Transform into F. tularensis and select for insertions

  • Verify disruption by PCR and sequencing

• CRISPR-Cas9 system:

  • Design guide RNAs targeting the pgi gene

  • Clone into a CRISPR-Cas9 vector with F. tularensis-compatible promoters

  • Transform into F. tularensis along with a repair template containing flanking homology regions

  • Select for edited cells and confirm by sequencing

Important considerations:

• Metabolic bypass strategies may be necessary if pgi is essential under standard conditions

• Supplementation with alternative carbon sources may be required for the growth of pgi mutants

• Confirming phenotypes requires careful physiological characterization under various growth conditions

• Complementation studies should be performed to validate that observed phenotypes are specifically due to pgi inactivation

How does pgi contribute to F. tularensis virulence and host-pathogen interactions?

The role of pgi in F. tularensis virulence involves several interconnected mechanisms that influence bacterial survival and replication within host cells:

Metabolic adaptation during infection:
F. tularensis undergoes significant metabolic reprogramming during infection, switching from oxidative metabolism in early stages to glycolysis, fatty acid oxidation, and gluconeogenesis in later stages . As a key enzyme at the interface of glycolysis and gluconeogenesis, pgi facilitates this metabolic flexibility, enabling the bacterium to adapt to changing nutrient availability within the host cell.

Energy homeostasis:
Systems biology approaches have demonstrated that F. tularensis depends on precisely regulated energy metabolism during infection . Pgi plays a critical role in maintaining energy homeostasis by directing carbon flux either toward energy production via glycolysis or toward biosynthetic pathways via the pentose phosphate pathway.

Connection to virulence regulatory networks:
Transcriptomic analyses have revealed that F. tularensis virulence factors are often co-regulated with metabolic genes. For example, the transcription elongation factor GreA has been shown to influence the expression of 196 bacterial genes, 77 of which are known virulence factors . The metabolic enzyme pgi may be part of this regulatory network, with its expression potentially influenced by key virulence regulators.

Experimental evidence from metabolic mutants:
Studies with metabolic mutants in F. tularensis have demonstrated that disruption of central carbon metabolism can significantly attenuate virulence. While specific data on pgi mutants is limited, related metabolic enzyme mutants show reduced intracellular growth and virulence in animal models, suggesting a similar role for pgi.

What are the kinetic differences between F. tularensis pgi and human glucose-6-phosphate isomerase?

Understanding the kinetic differences between bacterial and human glucose-6-phosphate isomerases is essential for developing selective inhibitors as potential therapeutics. Comparative analysis reveals several key differences:

These kinetic differences reflect evolutionary adaptations to their respective cellular environments and can be exploited for the development of selective inhibitors that target the bacterial enzyme while sparing the human homolog.

How can systems biology approaches integrate pgi function into the broader metabolic network of F. tularensis?

Systems biology approaches provide powerful tools for understanding how pgi functions within the broader metabolic network of F. tularensis, particularly during infection:

Flux Balance Analysis (FBA):
The metabolic reconstruction model iRS605 for F. tularensis includes 605 intra-system reactions and represents a comprehensive map of the organism's metabolism . FBA using this model has revealed that F. tularensis utilizes approximately 36% of its total metabolic capacity during growth on minimal media, which is higher than other bacteria like E. coli and Salmonella that use only 25% . This suggests a more streamlined metabolism in F. tularensis with less redundancy.

Metabolic network analysis:
Network analysis of F. tularensis metabolism has identified pgi as part of a core set of metabolic genes that are likely operational during infection . The position of pgi at the junction between glycolysis and gluconeogenesis makes it a key control point for redirecting carbon flux in response to changing environmental conditions.

Prediction of synthetic lethality:
Systems approaches can identify synthetic lethal interactions involving pgi, where the simultaneous inhibition of pgi and another enzyme would be lethal to the bacterium even if neither inhibition alone is fatal. This information is valuable for designing combination therapeutic strategies.

What are the prospects for developing selective inhibitors of F. tularensis pgi as potential therapeutics?

The development of selective inhibitors targeting F. tularensis pgi represents a promising approach for novel therapeutics against tularemia, particularly given the emergence of antibiotic resistance. Several factors support this strategy:

Rational drug design approaches:

• Structure-based virtual screening against the unique binding pockets of F. tularensis pgi

• Fragment-based drug discovery to identify small molecules that bind to specific regions of the enzyme

• Natural product screening, focusing on compounds known to target bacterial metabolic enzymes

• Allosteric inhibitor design targeting regulatory sites specific to the bacterial enzyme

Challenges and considerations:

• Developing inhibitors with sufficient potency, selectivity, and drug-like properties

• Ensuring adequate penetration into macrophages where F. tularensis resides

• Addressing potential metabolic bypass mechanisms that could confer resistance

• Optimizing pharmacokinetic properties for in vivo efficacy

Preliminary inhibitor classes:
Initial studies have identified several promising scaffold classes including phosphonate derivatives, substrate analogs, and natural product-inspired compounds that show selective inhibition of bacterial pgi enzymes over human homologs.

How might CRISPR-based approaches enhance our understanding of pgi function in F. tularensis?

CRISPR technology offers powerful new approaches for investigating pgi function in F. tularensis, enabling precise genetic manipulation and functional genomics studies:

CRISPR interference (CRISPRi) for conditional knockdown:
Unlike traditional knockout approaches, CRISPRi allows for titratable gene repression, enabling the study of essential genes like pgi without complete loss of function. This approach has already been trialed in Streptomyces and could be adapted for F. tularensis . The system uses catalytically inactive Cas9 (dCas9) or Cpf1 (dCpf1) to bind target sequences and block transcription.

CRISPR-based screens:
Genome-wide or targeted CRISPR screens can identify genetic interactions with pgi, revealing synthetic lethal relationships and functional connections within metabolic networks. This information could reveal new therapeutic targets and provide insights into the broader metabolic context of pgi function.

Base editing and prime editing:
These newer CRISPR technologies enable precise nucleotide changes without double-strand breaks, allowing for the introduction of specific mutations in the pgi gene to study structure-function relationships. This could be particularly valuable for investigating how specific residues contribute to substrate binding, catalysis, and regulation.

Implementation challenges for F. tularensis:

• Optimizing guide RNA design for high efficiency and specificity

• Developing delivery methods suitable for F. tularensis

• Adapting CRISPR systems to function optimally in this organism

• Addressing biosafety concerns when working with highly virulent strains

What is the role of pgi in F. tularensis adaptation to different host environments and stress conditions?

F. tularensis encounters diverse environments during its infectious cycle, from external environments to various host cell types and tissues. The role of pgi in adaptation to these changing conditions involves several key aspects:

Nutrient adaptation:
F. tularensis must adapt to varying carbon sources within different host compartments. Flux balance analysis of the F. tularensis metabolic network has demonstrated that amino acids can provide all the bulk carbon requirements for growth, but the organism still maintains flexibility to utilize other carbon sources . Pgi plays a critical role in this metabolic flexibility by enabling the interconversion between glucose-6-phosphate and fructose-6-phosphate.

Oxidative stress response:
During infection, F. tularensis faces oxidative stress from host defense mechanisms. The pentose phosphate pathway, which branches from glucose-6-phosphate (the substrate of pgi), is critical for generating NADPH needed for antioxidant defense. Regulation of carbon flux through pgi versus the pentose phosphate pathway may therefore be an important part of the oxidative stress response.

pH adaptation:
F. tularensis encounters varying pH conditions during infection, from the acidic environment of the phagosome to the neutral pH of the cytosol. Systems biology approaches have identified acid resistance as a key attribute of F. tularensis, with changes in carbohydrate utilization playing a pivotal role . As a central metabolic enzyme, pgi likely contributes to this pH adaptation.

Temporal regulation during infection:
Transcriptomic analyses have revealed a shift in F. tularensis metabolism during infection, from oxidative metabolism early to fatty acid oxidation and gluconeogenesis later . This suggests that pgi function may change over the course of infection, potentially switching its predominant direction of catalysis to support different metabolic demands.

Experimental approaches to study adaptation:

• Stress exposure experiments with wild-type and pgi-modified strains

• Metabolic flux analysis using isotope labeling under different conditions

• Transcriptomic and proteomic profiling to monitor pgi expression in response to environmental changes

• In vivo infection models to track pgi activity during different stages of pathogenesis

What are the biosafety considerations when working with recombinant F. tularensis proteins?

Working with recombinant F. tularensis proteins, including pgi, requires careful attention to biosafety due to the highly pathogenic nature of this organism. Researchers should follow these guidelines:

Biosafety level requirements:

• Work with virulent F. tularensis subsp. tularensis (Type A) requires Biosafety Level 3 (BSL-3) containment

• Attenuated strains like LVS or F. novicida may be handled at BSL-2 with enhanced practices

• Purified recombinant proteins expressed in heterologous hosts (e.g., E. coli) typically can be handled at BSL-1 or BSL-2, depending on institutional policies

Key precautions for recombinant protein work:

• Confirm complete absence of viable F. tularensis in recombinant protein preparations

• Implement rigorous quality control testing before downgrading biosafety levels

• Use appropriate personal protective equipment (PPE) including gloves, lab coat, and eye protection

• Conduct all aerosol-generating procedures in biological safety cabinets

• Decontaminate all work surfaces and equipment with appropriate disinfectants

• Follow institutional and national guidelines for biological waste disposal

Documentation requirements:

• Maintain detailed records of all experimental protocols

• Document risk assessments for specific procedures

• Keep training records for all personnel

• Register research with appropriate institutional biosafety committees

• Obtain necessary permits for possession of select agent-derived materials, if applicable

How can I validate that recombinant F. tularensis pgi maintains native structural and functional characteristics?

Ensuring that recombinant F. tularensis pgi accurately represents the native enzyme is crucial for the validity of research findings. Multiple complementary approaches should be used for validation:

Structural validation:

• Circular dichroism (CD) spectroscopy to confirm secondary structure composition

• Thermal shift assays to assess protein stability

• Size exclusion chromatography to verify oligomeric state

• Limited proteolysis to evaluate conformational integrity

• X-ray crystallography or cryo-EM for detailed structural comparison with homologous enzymes

Functional validation:

• Enzyme kinetics (Km, kcat, substrate specificity) compared to reported values for related enzymes

• pH and temperature activity profiles to ensure physiological relevance

• Response to known regulators and inhibitors of bacterial pgi enzymes

• Metal ion requirements and binding characteristics

• Isothermal titration calorimetry to measure thermodynamic parameters of substrate binding

Complementation studies:
If possible, testing whether the recombinant enzyme can restore function in a pgi-deficient bacterial strain provides strong evidence of native functionality. This can be performed in a heterologous host like E. coli with a pgi deletion or, ideally, in an F. tularensis pgi mutant strain.

Analytical validation:

What are the most effective ways to integrate computational and experimental approaches in studying F. tularensis pgi?

Integrating computational and experimental approaches creates powerful synergies for studying F. tularensis pgi, enabling deeper insights than either approach alone could provide:

Computational-experimental integration workflow:

• Structure prediction and validation:

  • Use homology modeling and AlphaFold2 to predict pgi structure

  • Validate predictions with experimental structural data (X-ray, cryo-EM)

  • Guide mutagenesis studies to test structural hypotheses

• Metabolic modeling and flux analysis:

  • Incorporate pgi into genome-scale metabolic models of F. tularensis

  • Make predictions about metabolic responses to pgi perturbation

  • Validate predictions with metabolomics and 13C-flux analysis experiments

• Molecular dynamics and enzyme mechanism:

  • Simulate substrate binding and catalytic mechanisms

  • Identify potential allosteric sites and conformational changes

  • Test predictions with enzyme kinetics and biophysical binding assays

• Systems-level analysis:

  • Predict gene-gene interactions involving pgi using network analysis

  • Identify potential regulatory mechanisms affecting pgi expression

  • Validate with transcriptomics, proteomics, and targeted genetic studies

Specific integrated approaches:

This integrated approach leverages the predictive power of computational methods while ensuring biological relevance through experimental validation, creating a robust framework for studying F. tularensis pgi in the context of metabolism, pathogenesis, and potential therapeutic targeting.